Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

[Care of patients with Parkinson's disease in Germany].

Stangl S, Haas K, Eggers C, Reese JP, Tönges L, Volkmann J.

Nervenarzt. 2020 Mar 18. doi: 10.1007/s00115-020-00890-4. [Epub ahead of print] Review. German.

PMID:
32189041
2.

Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study.

Reichmann H, Lees A, Rocha JF, Magalhães D, Soares-da-Silva P; OPTIPARK investigators.

Transl Neurodegener. 2020 Mar 4;9:9. doi: 10.1186/s40035-020-00187-1. eCollection 2020.

3.

Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease.

Hegelmaier T, Lebbing M, Duscha A, Tomaske L, Tönges L, Holm JB, Bjørn Nielsen H, Gatermann SG, Przuntek H, Haghikia A.

Cells. 2020 Feb 6;9(2). pii: E376. doi: 10.3390/cells9020376.

4.

Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein.

Barkovits K, Kruse N, Linden A, Tönges L, Pfeiffer K, Mollenhauer B, Marcus K.

Cells. 2020 Feb 5;9(2). pii: E370. doi: 10.3390/cells9020370.

5.

Motor, cognitive and mobility deficits in 1000 geriatric patients: protocol of a quantitative observational study before and after routine clinical geriatric treatment - the ComOn-study.

Geritz J, Maetzold S, Steffen M, Pilotto A, Corrà MF, Moscovich M, Rizzetti MC, Borroni B, Padovani A, Alpes A, Bang C, Barcellos I, Baron R, Bartsch T, Becktepe JS, Berg D, Bergeest LM, Bergmann P, Bouça-Machado R, Drey M, Elshehabi M, Farahmandi S, Ferreira JJ, Franke A, Friederich A, Geisler C, Hüllemann P, Gierthmühlen J, Granert O, Heinzel S, Heller MK, Hobert MA, Hofmann M, Jemlich B, Kerkmann L, Knüpfer S, Krause K, Kress M, Krupp S, Kudelka J, Kuhlenbäumer G, Kurth R, Leypoldt F, Maetzler C, Maia LF, Moewius A, Neumann P, Niemann K, Ortlieb CT, Paschen S, Pham MH, Puehler T, Radloff F, Riedel C, Rogalski M, Sablowsky S, Schanz EM, Schebesta L, Schicketmüller A, Studt S, Thieves M, Tönges L, Ullrich S, Urban PP, Vila-Chã N, Wiegard A, Warmerdam E, Warnecke T, Weiss M, Welzel J, Hansen C, Maetzler W.

BMC Geriatr. 2020 Feb 6;20(1):45. doi: 10.1186/s12877-020-1445-z.

6.

The Progressive Supranuclear Palsy Clinical Deficits Scale.

Piot I, Schweyer K, Respondek G, Stamelou M; DescribePSP study group; ProPSP study group; MDS-endorsed PSP study group, Sckopke P, Schenk T, Goetz CG, Stebbins GT, Höglinger GU.

Mov Disord. 2020 Jan 17. doi: 10.1002/mds.27964. [Epub ahead of print]

PMID:
31951049
7.

Association of Blood Pressure With Outcomes in Acute Stroke Thrombectomy.

Malhotra K, Goyal N, Katsanos AH, Filippatou A, Mistry EA, Khatri P, Anadani M, Spiotta AM, Sandset EC, Sarraj A, Magoufis G, Krogias C, Tönges L, Safouris A, Elijovich L, Goyal M, Arthur A, Alexandrov AV, Tsivgoulis G.

Hypertension. 2020 Mar;75(3):730-739. doi: 10.1161/HYPERTENSIONAHA.119.14230. Epub 2020 Jan 13.

PMID:
31928111
8.

Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology.

Richter D, Katsanos AH, Schroeder C, Tsivgoulis G, Paraskevas GP, Müller T, Alexandrov AV, Gold R, Tönges L, Krogias C.

Cells. 2019 Dec 18;9(1). pii: E2. doi: 10.3390/cells9010002.

9.

Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.

Scherbaum R, Hartelt E, Kinkel M, Gold R, Muhlack S, Tönges L.

J Neurol. 2019 Dec 3. doi: 10.1007/s00415-019-09657-7. [Epub ahead of print]

PMID:
31797086
10.

Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease.

Maass F, Michalke B, Willkommen D, Leha A, Schulte C, Tönges L, Mollenhauer B, Trenkwalder C, Rückamp D, Börger M, Zerr I, Bähr M, Lingor P.

Neurobiol Dis. 2020 Feb;134:104677. doi: 10.1016/j.nbd.2019.104677. Epub 2019 Nov 13.

11.

Selenium speciation analysis in the cerebrospinal fluid of patients with Parkinson's disease.

Maass F, Michalke B, Willkommen D, Schulte C, Tönges L, Boerger M, Zerr I, Bähr M, Lingor P.

J Trace Elem Med Biol. 2020 Jan;57:126412. doi: 10.1016/j.jtemb.2019.126412. Epub 2019 Sep 24.

PMID:
31582281
12.

CSF Sample Preparation for Data-Independent Acquisition.

Barkovits K, Tönges L, Marcus K.

Methods Mol Biol. 2019;2044:61-67. doi: 10.1007/978-1-4939-9706-0_4.

PMID:
31432406
13.

Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis.

Ayzenberg I, Ellrichmann G, Schroeder C, Tönges L, Klasing A, Pappa V, Brück W, Gold R.

Front Neurol. 2019 Aug 2;10:829. doi: 10.3389/fneur.2019.00829. eCollection 2019.

14.

Fingolimod for Irradiation-Induced Neurodegeneration.

Metzdorf J, Hobloss Z, Schlevogt S, Ayzenberg I, Stahlke S, Pedreiturria X, Haupeltshofer S, Gold R, Tönges L, Kleiter I.

Front Neurosci. 2019 Jul 9;13:699. doi: 10.3389/fnins.2019.00699. eCollection 2019.

15.

Antibody-based immunotherapies for Parkinsonian syndromes.

Tönges L, Zella MAS.

Neural Regen Res. 2019 Nov;14(11):1903-1904. doi: 10.4103/1673-5374.259613. No abstract available.

16.

Reversible Immuno-Infrared Sensor for the Detection of Alzheimer's Disease Related Biomarkers.

Budde B, Schartner J, Tönges L, Kötting C, Nabers A, Gerwert K.

ACS Sens. 2019 Jul 26;4(7):1851-1856. doi: 10.1021/acssensors.9b00631. Epub 2019 Jul 10.

PMID:
31241315
17.

Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.

Richter D, Bartig D, Jost W, Jörges C, Stumpe B, Gold R, Krogias C, Tönges L.

J Neural Transm (Vienna). 2019 Jul;126(7):879-888. doi: 10.1007/s00702-019-02034-8. Epub 2019 Jun 20.

PMID:
31222604
18.

Dyskinesia in multiple system atrophy and progressive supranuclear palsy.

Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J, Schrag A.

J Neural Transm (Vienna). 2019 Jul;126(7):925-932. doi: 10.1007/s00702-019-02012-0. Epub 2019 May 13. Review.

PMID:
31087195
19.

Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010⁻2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers.

Richter D, Bartig D, Muhlack S, Hartelt E, Scherbaum R, Katsanos AH, Müller T, Jost W, Ebersbach G, Gold R, Krogias C, Tönges L.

Cells. 2019 Feb 11;8(2). pii: E151. doi: 10.3390/cells8020151.

20.

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.

Zella MAS, Metzdorf J, Ostendorf F, Maass F, Muhlack S, Gold R, Haghikia A, Tönges L.

Cells. 2019 Jan 31;8(2). pii: E105. doi: 10.3390/cells8020105. Review.

Supplemental Content

Loading ...
Support Center